Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK — a multicentre observational study

Deepa RJ Arachchillage, Indika Rajakurana, Zain Odho, Christina Crossette-Thambiah, Pip Nicolson, Lara Roberts, Caroline Allan, Sarah Lewis, Renu Riat, Philip Mounter, Ceri Lynch, Alexander Langridge, Roderick Oakes, Nini Aung, Anja Drebes, Tina Dutt, Priyanka Raheja, Alison Delaney, Sarah Essex, Gillian LoweDavid Sutton, Claire Lentaigne, Zara Sayar, Mari Kilner, Tamara Everington, Susie Shapiro, Raza Alikhan, R Szydlo, Mike Makris, Michael Laffan

Research output: Contribution to journalArticlepeer-review

Abstract

Coagulation dysfunction and thrombosis are major complications in patients with COVID-19. Patients on oral anticoagulants (OAC) prior to diagnosis of COVID-19 may therefore have better outcomes. In this multicentre observational study of 5883 patients (≥18 years) admitted to 26 UK hospitals between 1st of April to 31 July 2020, overall mortality was 29.2%. Incidences of thrombosis, major bleeding (MB) and multiorgan failure (MOF) were 5.4%,1.7% and 3.3% respectively. The presence of thrombosis, MB, or MOF were associated with a 1.8, 4.5 or 5.9-fold increased risk of dying, respectively.

Of the 5883 patients studied, 83.6% (n=4920) were not on OAC and 16.4% (n=963) were taking OAC at the time of admission. There was no difference in mortality between patients on OAC vs no OAC prior to admission when compared in an adjusted multivariate analysis (HR1.05(95%CI 0.93-1.19),P=0.15) or in an adjusted propensity score analysis (HR0.92(95%CI0.58-1.450, P=0.18). In multivariate and adjusted propensity score analyses, the only significant association of no anticoagulation prior to diagnosis of COVID-19 was admission to ICU (HR1.98[95%CI1.37-2.85]). Thrombosis, MB, and MOF were associated with higher mortality. Our results indicate that patients may have benefit from prior OAC use especially reduced admission to ICU, without any increase in bleeding.
Original languageEnglish
JournalBritish Journal of Haematology
Early online date9 Sep 2021
DOIs
Publication statusE-pub ahead of print - 9 Sep 2021

Fingerprint

Dive into the research topics of 'Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK — a multicentre observational study'. Together they form a unique fingerprint.

Cite this